Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
MCRB - Seres Therapeutics Inc - Stock Price Chart
TickerMCRB [NASD]
CompanySeres Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap103.65MEPS (ttm)-9.99
P/E-EPS this Y-
Forward P/E-EPS next Y-746.32%
PEG-EPS past 5Y5.33%
P/S-EPS next 5Y-
P/B2.05EPS Q/Q168.26%
Dividend-Sales Q/Q-
Insider Own26.28%Inst Own21.98%
Insider Trans-1.26%Inst Trans-43.19%
Short Float10.55%EarningsMay 07/b
Analyst Recom2.60Target Price13.33
Avg Volume111.29K52W Range6.53 - 30.60
RCT - RedCloud Holdings PLC - Stock Price Chart
TickerRCT [NASD]
CompanyRedCloud Holdings PLC
CountryUnited Kingdom
IndustrySoftware - Application
Market Cap110.12MEPS (ttm)-1.07
P/E-EPS this Y75.68%
Forward P/E33.20EPS next Y121.13%
PEG-EPS past 5Y-
P/S2.94EPS next 5Y-
P/B-EPS Q/Q-11.28%
Dividend-Sales Q/Q166.95%
Insider Own88.53%Inst Own2.58%
Insider Trans0.00%Inst Trans64.30%
Short Float0.44%EarningsFeb 26
Analyst Recom1.00Target Price5.33
Avg Volume1.63M52W Range1.17 - 5.36
DLPN - Dolphin Entertainment Inc - Stock Price Chart
TickerDLPN [NASD]
CompanyDolphin Entertainment Inc
CountryUSA
IndustryAdvertising Agencies
Market Cap14.30MEPS (ttm)-2.14
P/E-EPS this Y95.90%
Forward P/E2.98EPS next Y960.00%
PEG-EPS past 5Y13.82%
P/S0.29EPS next 5Y-
P/B1.53EPS Q/Q-467.12%
Dividend-Sales Q/Q-20.12%
Insider Own39.31%Inst Own4.16%
Insider Trans2.10%Inst Trans-7.53%
Short Float0.57%EarningsMay 13/a
Analyst Recom1.00Target Price5.00
Avg Volume24.95K52W Range0.75 - 2.00
MNTS - Momentus Inc - Stock Price Chart
TickerMNTS [NASD]
CompanyMomentus Inc
CountryUSA
IndustryAerospace & Defense
Market Cap8.07MEPS (ttm)-18.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S4.20EPS next 5Y-
P/B-EPS Q/Q82.25%
Dividend-Sales Q/Q-37.23%
Insider Own3.74%Inst Own5.72%
Insider Trans0.00%Inst Trans379.26%
Short Float6.64%Earnings-
Analyst Recom1.00Target Price57.40
Avg Volume1.12M52W Range1.03 - 28.56
BKKT - Bakkt Holdings Inc - Stock Price Chart
TickerBKKT [NYSE]
CompanyBakkt Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap256.29MEPS (ttm)-4.89
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-14.18%
P/S0.07EPS next 5Y-
P/B2.74EPS Q/Q163.56%
Dividend-Sales Q/Q25.78%
Insider Own14.19%Inst Own20.09%
Insider Trans-1.43%Inst Trans0.20%
Short Float23.72%EarningsMay 12/a
Analyst Recom3.00Target Price13.00
Avg Volume422.68K52W Range6.81 - 37.21
EXOD - Exodus Movement Inc - Stock Price Chart
TickerEXOD [AMEX]
CompanyExodus Movement Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap947.02MEPS (ttm)1.76
P/E18.61EPS this Y-74.72%
Forward P/E16.67EPS next Y121.07%
PEG-EPS past 5Y-
P/S7.69EPS next 5Y-
P/B3.89EPS Q/Q-125.80%
Dividend-Sales Q/Q23.87%
Insider Own72.73%Inst Own2.80%
Insider Trans-0.03%Inst Trans1.09%
Short Float5.10%EarningsMay 12/a
Analyst Recom1.00Target Price60.75
Avg Volume121.74K52W Range12.02 - 117.40
DBVT - DBV Technologies ADR - Stock Price Chart
TickerDBVT [NASD]
CompanyDBV Technologies ADR
CountryFrance
IndustryBiotechnology
Market Cap317.14MEPS (ttm)-5.77
P/E-EPS this Y-116.31%
Forward P/E-EPS next Y-1.36%
PEG-EPS past 5Y24.05%
P/S-EPS next 5Y12.64%
P/B82.87EPS Q/Q7.19%
Dividend-Sales Q/Q-
Insider Own0.04%Inst Own42.51%
Insider Trans-8.35%Inst Trans38.68%
Short Float0.08%EarningsApr 30/a
Analyst Recom1.67Target Price18.52
Avg Volume71.68K52W Range2.20 - 12.78
UUU - Universal Security Instruments, Inc - Stock Price Chart
TickerUUU [AMEX]
CompanyUniversal Security Instruments, Inc
CountryUSA
IndustrySecurity & Protection Services
Market Cap7.68MEPS (ttm)-0.55
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y21.74%
P/S0.35EPS next 5Y-
P/B1.85EPS Q/Q-1016.29%
Dividend-Sales Q/Q18.91%
Insider Own11.09%Inst Own22.86%
Insider Trans4.06%Inst Trans0.16%
Short Float0.61%Earnings-
Analyst Recom-Target Price-
Avg Volume40.41K52W Range1.11 - 3.20
MASK - 3 E Network Technology Group Ltd - Stock Price Chart
TickerMASK [NASD]
Company3 E Network Technology Group Ltd
CountryChina
IndustrySoftware - Application
Market Cap26.32MEPS (ttm)0.17
P/E13.68EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.58EPS next 5Y-
P/B6.97EPS Q/Q56.25%
Dividend-Sales Q/Q5.25%
Insider Own-Inst Own0.89%
Insider Trans-Inst Trans8.04%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume60.97K52W Range2.00 - 4.19
ANNX - Annexon Inc - Stock Price Chart
TickerANNX [NASD, RUT]
CompanyAnnexon Inc
CountryUSA
IndustryBiotechnology
Market Cap317.07MEPS (ttm)-1.17
P/E-EPS this Y-45.07%
Forward P/E-EPS next Y1.20%
PEG-EPS past 5Y-0.09%
P/S-EPS next 5Y2.82%
P/B1.30EPS Q/Q-78.85%
Dividend-Sales Q/Q-
Insider Own12.93%Inst Own87.98%
Insider Trans-0.27%Inst Trans-5.91%
Short Float10.60%EarningsMay 12/b
Analyst Recom1.00Target Price11.60
Avg Volume1.59M52W Range1.28 - 7.85
Jun-18-25 04:05PM Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) (GlobeNewswire)
May-29-25 04:05PM Annexon Biosciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +7.39% -6.42%
May-19-25 04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
May-16-25 04:05PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.05%
May-12-25 08:00AM Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones (GlobeNewswire) +10.62%
May-09-25 05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire) -5.88%
05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barre Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire)
May-07-25 08:00AM Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress (GlobeNewswire)
Apr-16-25 04:05PM Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.14%
110121314151617181920